These results already show that the deregulated expression of both IL-7 and its receptor can contribute to the development of lymphoid malignancies, as well as that T-ALL cells often remain dependent on IL-7-induced signaling for survival, cell cycle progression and proliferation. Here, IL7 is linked to acute lymphoblastic leukemia.